Amendment of the Genetically Modified Organisms (Contained Use) Regulations 2014U.K.
This section has no associated Explanatory Memorandum
12. In regulation 3(2)(b) of the Genetically Modified Organisms (Contained Use) Regulations 2014 (application) M1, at the end insert—
“; or
(iv)a medicinal product for human use marketed in accordance with the Human Medicines Regulations 2012;”.
Commencement Information
I1Sch. 8 para. 12 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1
Marginal Citations